<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35567664</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1434-9949</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical rheumatology</Title>
          <ISOAbbreviation>Clin Rheumatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mapping theme trends and knowledge structure of Sjögren's syndrome (SS), a bibliometric analysis from 2010 to 2021.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-022-06196-x</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sjögren's syndrome is an autoimmune disease with a complicated pathophysiology, and treatment strategies are in desperate need of improvement. In this research, we provide the literature topic trends and knowledge structure connected to Sjögren's syndrome from the perspective of bibliometrics for further research.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We acquired 3753 publications from the PubMed database and 3880 catalogs from the Web of Science Core Collection, with a time limit of 2010 to 2021 and the search term as "Sjögren's syndrome." Using the VOSviewer and bibliographic item co-occurrence matrix generator, we conducted cocited analysis, extracted major MeSH terms, generated matrices and performed biclustering analysis, visual matrix, drawn strategy diagram, and social network analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Through the clustering of the major MeSH terms, a total of five categories and 10 research topics were identified. Cocitation analysis suggests that diagnosis and clinical manifestations have been the main basis over the past 12 years and also are the mature content in the first quadrant of the strategy map. Ultrasonography, immunosuppressive agents and therapy, mechanism and therapeutic targets, and diagnostic autoantibodies are examples of the third quadrant, which wields great potential to progress. Genetic predisposition and psychology, in the fourth quadrant, need to be developed additionally. The subject keywords near the network's edge, such as "Salivary Glands, Minor/pathology," "Immunosuppressive Agents/therapeutic use," and "Autoantibodies/blood," are all growing research hotspots with much space, according to social network analysis.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Through bibliometric analysis of the literature related to Sjögren's syndrome in the past 12 years, we obtained the knowledge basis, undeveloped topics, and emerging hotspots, which can suggest recommendations for future research. Key Points • We disclosed the topic trends and knowledge structure of Sjögren's syndrome literature over the past 12 years. • Clinical manifestations and diagnosis of Sjögren syndrome are included in mature and comprehensive studies, whereas ultrasonography, immunosuppressants and treatments, mechanisms and therapeutic targets, and diagnostic autoantibodies are studies with high potential for advancement. Additional research in genetics and psychology is needed. • We identified potential future research hotspots, including "Salivary Glands, Minor/pathology," "Immunosuppressive Agents/therapeutic use," and "Autoantibodies/blood."</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0001-7557-4015</Identifier>
            <AffiliationInfo>
              <Affiliation>School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, 110002, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Bowen</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0002-2255-2573</Identifier>
            <AffiliationInfo>
              <Affiliation>School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, 110002, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Jialin</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0001-6010-2517</Identifier>
            <AffiliationInfo>
              <Affiliation>School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, 110002, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yi</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0002-4640-3396</Identifier>
            <AffiliationInfo>
              <Affiliation>School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, 110002, China. liuyi@cmu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Clin Rheumatol</MedlineTA>
        <NlmUniqueID>8211469</NlmUniqueID>
        <ISSNLinking>0770-3198</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Biclustering analysis</Keyword>
        <Keyword MajorTopicYN="N">Cocited analysis</Keyword>
        <Keyword MajorTopicYN="N">Coword analysis</Keyword>
        <Keyword MajorTopicYN="N">Hot research topics</Keyword>
        <Keyword MajorTopicYN="N">Sjögren’s syndrome</Keyword>
        <Keyword MajorTopicYN="N">Social network analysis</Keyword>
        <Keyword MajorTopicYN="N">Strategic diagram</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>11</Hour>
          <Minute>16</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35567664</ArticleId>
        <ArticleId IdType="doi">10.1007/s10067-022-06196-x</ArticleId>
        <ArticleId IdType="pii">10.1007/s10067-022-06196-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Shiboski SC, Shiboski CH, Criswell LA et al (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort [J]. Arthritis Care Res (Hoboken) 64(4):475–487</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.21591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brito-Zeron P, Baldini C, Bootsma H et al (2016) Sjogren syndrome [J]. Nat Rev Dis Primers 2</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao F, Du F, Shi D et al (2019) Mapping research trends of retinal vein occlusion from 2009 to 2018: a bibliometric analysis [J]. PeerJ:7e7603</Citation>
        </Reference>
        <Reference>
          <Citation>Wei W-J, Shi B, Guan X et al (2019) Mapping theme trends and knowledge structures for human neural stem cells: a quantitative and co-word biclustering analysis for the 2013-2018 period [J]. Neural Regen Res 14(10):1823–1832</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/1673-5374.257535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao F, Shi B, Liu R et al (2018) Theme trends and knowledge structure on choroidal neovascularization: a quantitative and co-word analysis [J]. BMC Ophthalmol 18(1):86</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12886-018-0752-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirsch JE (2005) An index to quantify an individual’s scientific research output [J]. Proc Natl Acad Sci U S A 102(46):16569–16572</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0507655102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Eck NJ, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping [J]. Scientometrics 84(2):523–538</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11192-009-0146-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li F, Zhou H, Huang D-S et al (2020) Global research output and theme trends on climate change and infectious diseases: a restrospective bibliometric and co-word biclustering investigation of papers indexed in PubMed (1999-2018) [J]. Int J Environ Res Public Health:17(14)</Citation>
        </Reference>
        <Reference>
          <Citation>Gao W, Yang L, Shi B (2021) Mapping themes trends and knowledge structure of trophoblastic invasion, a bibliometric analysis from 2012-2021 [J]. J Reprod Immunol 146103347</Citation>
        </Reference>
        <Reference>
          <Citation>Law J, Bauin S, Courtial JP et al (1988) Policy and the mapping of scientific change: a co-word analysis of research into environmental acidification [J]. Scientometrics 14(3–4):251–264</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF02020078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyu X, Hu J, Dong W et al (2020) Intellectual structure and evolutionary trends of precision medicine research: coword analysis [J]. JMIR Med Inform 8(2):e11287</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2196/11287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Callon M, Courtial JP, Laville F (1991) Co-word analysis as a tool for describing the network of interactions between basic and technological research [J]. the case of polymer chemistry. Scientometrics 22:155–205</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF02019280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiboski CH, Shiboski SC, Seror R et al (2017) 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts [J]. Arthritis Rheumatol 69(1):35–45</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.39859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group [J]. Ann Rheum Dis 61(6):554–558</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ard.61.6.554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geng Y, Li B, Deng X et al (2020) Salivary gland ultrasound integrated with 2016 ACR/EULAR classification criteria improves the diagnosis of primary Sjögren’s syndrome [J]. Clin Exp Rheumatol 38(2):322–328</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31994484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milic VD, Petrovic RR, Boricic IV et al (2010) Major salivary gland sonography in Sjögren's syndrome: diagnostic value of a novel ultrasonography score (0-12) for parenchymal inhomogeneity [J]. Scand J Rheumatol 39(2):160–166</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/03009740903270623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen H, Qi X, Li Y et al (2021) Iguratimod treatment reduces disease activity in early primary Sjögren’s syndrome: an open-label pilot study [J]. Mod Rheumatol 31(2):394–398</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14397595.2020.1789335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Vita S, Quartuccio L, Seror R et al (2015) Efficacy and safety of belimumab given for 12 months in primary Sjögren’s syndrome: the BELISS open-label phase II study [J]. Rheumatology (Oxford) 54(12):2249–2256</Citation>
        </Reference>
        <Reference>
          <Citation>Lieberman SM (2013) Childhood Sjögren syndrome: insights from adults and animal models [J]. Curr Opin Rheumatol 25(5):651–657</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0b013e328363ed23</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fox RI, Fox CM, Gottenberg JE et al (2021) Treatment of Sjögren’s syndrome: current therapy and future directions [J]. Rheumatology (Oxford) 60(5):2066–2074</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kez142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mavragani CP, Moutsopoulos HM (2020) Sjögren’s syndrome: old and new therapeutic targets [J]. J Autoimmun 110102364</Citation>
        </Reference>
        <Reference>
          <Citation>Smith PM, Dawson LJ (2012) Autoantibodies and Sjögren’s syndrome: a physiologist’s perspective [J]. Curr Pharm Biotechnol 13(10):2063–2070</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/138920112802273218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guisado-Vasco P, Silva M, Duarte-Millán MA et al (2019) Quantitative assessment of interstitial lung disease in Sjögren’s syndrome [J]. PLoS One 14(11):e0224772</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0224772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strevens Bolmgren V, Olsson P, Wollmer P et al (2017) Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sjögren’s syndrome [J]. Rheumatol Int 37(5):813–818</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00296-017-3678-5</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
